EFDID: 521517EFD: View Filing

Issuer: MyMD Pharmaceuticals, Inc. (0001321834) - D

Accession: 0001493152-24-022083 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001321834
  • Entity Name:
    MyMD Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2023)
  • Address:
    855 N. WOLFE STREET
    SUITE 623
    BALTIMORE, MD 21205
  • Persons:
    Related Persons 8
    Chris Chapman
    Executive Officer 
    President, Chief Medical Officer, and Director
    Ian Rhodes
    Executive Officer 
    Chief Financial Officer
    Craig Eagle
    Director
    Christopher Schreiber
    Director
    Joshua Silverman
    Director
    Jude Uzonwanne
    Director
    Bill J. White
    Director
    Mitchell Glass
    Director
EDGAR: Offering Information
  • Accession Date:
    05/31/2024
  • First Sale Date:
    05/20/2024
  • Offering Amount:
    $15,150,007
  • Amount Sold:
    $15,150,007
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Includes aggregate exercise price of warrants of $1.816 (subject to price-based adjustment), that may be received upon exercise of the warrants
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Palladium Capital Group, LLC 000129400 None None NY
GP Nurmenkari Inc. 000153480 None None NY, CT
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
MyMD Pharmaceuticals, Inc./s/ Chris ChapmanChris ChapmanPresident and Chief Medical Officer2024-05-31